BPC-157 Prevents Tolerance and Physical Dependence From Chronic Diazepam Use in Rats
Co-administering BPC-157 with daily diazepam prevented the development of tolerance and physical dependence in rats, while also reducing withdrawal seizures — a remarkable protective effect.
Quick Facts
What This Study Found
BPC-157 co-administration with chronic diazepam (10 days) prevented tolerance development, maintained anticonvulsant efficacy, and reduced withdrawal seizure severity at both 10 μg/kg and 10 ng/kg doses in rats.
Key Numbers
How They Did This
Animal study in rats. BPC-157 (10 μg/kg or 10 ng/kg IP) was co-administered with diazepam (5 mg/kg IP) twice daily for 10 days. Anticonvulsant efficacy, tolerance, and pentylenetetrazol-induced withdrawal seizures were assessed.
Why This Research Matters
Benzodiazepine dependence is a major clinical problem. A co-treatment that prevents tolerance and dependence without interfering with the therapeutic effect would transform how these medications are used.
The Bigger Picture
Millions of people take benzodiazepines for anxiety and insomnia, but dependence develops within weeks. A peptide that prevents this dependence while maintaining therapeutic benefit could eliminate one of psychiatry's most challenging medication problems.
What This Study Doesn't Tell Us
Rat study only. The GABAergic interaction mechanism was not fully elucidated. Translation to human benzodiazepine use is unknown. 10-day timeframe may not reflect longer-term dependence patterns.
Questions This Raises
- ?Could BPC-157 help patients taper off benzodiazepines?
- ?Does BPC-157 affect GABA receptors directly or modulate them indirectly?
- ?Would this protective effect extend to other sedative-hypnotic drugs?
Trust & Context
- Key Stat:
- Active at nanogram doses BPC-157 prevented diazepam tolerance and dependence at both microgram and nanogram doses — extremely potent protective effect
- Evidence Grade:
- Preliminary animal evidence with clear behavioral endpoints and dose-response data, but no human studies or mechanistic confirmation.
- Study Age:
- Published in 1999. BPC-157's interaction with GABAergic and dopaminergic systems has been studied further, but human data remains absent.
- Original Title:
- The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam.
- Published In:
- The Chinese journal of physiology, 42(3), 171-9 (1999)
- Authors:
- Jelovac, N(9), Sikiric, P(36), Rucman, R(29), Petek, M, Perovic, D, Marovic, A, Anic, T, Seiwerth, S, Mise, S, Pigac, B, Duplancie, B, Turkovic, B, Dodig, G, Prkacin, I, Stancic-Rokotov, D, Zoricic, I, Aralica, G, Sebecic, B, Ziger, T, Slobodnjak, Z
- Database ID:
- RPEP-00529
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is benzodiazepine dependence?
When taken daily for even a few weeks, benzodiazepines like diazepam (Valium) lose effectiveness (tolerance) and the body becomes dependent, causing potentially dangerous withdrawal seizures when stopped.
Could BPC-157 help people on benzodiazepines?
This animal study suggests BPC-157 prevents the brain changes that cause benzodiazepine dependence. If confirmed in humans, it could be co-prescribed with benzodiazepines to prevent dependence — but human studies haven't been done yet.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00529APA
Jelovac, N; Sikiric, P; Rucman, R; Petek, M; Perovic, D; Marovic, A; Anic, T; Seiwerth, S; Mise, S; Pigac, B; Duplancie, B; Turkovic, B; Dodig, G; Prkacin, I; Stancic-Rokotov, D; Zoricic, I; Aralica, G; Sebecic, B; Ziger, T; Slobodnjak, Z. (1999). The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam.. The Chinese journal of physiology, 42(3), 171-9.
MLA
Jelovac, N, et al. "The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam.." The Chinese journal of physiology, 1999.
RethinkPeptides
RethinkPeptides Research Database. "The effect of a novel pentadecapeptide BPC 157 on developmen..." RPEP-00529. Retrieved from https://rethinkpeptides.com/research/jelovac-1999-the-effect-of-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.